Company intelligence / Profile preview

Jiangsu Renji Pharmaceutical Chain

Taizhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Jiangsu Renji Pharmaceutical Chain is a Taizhou-based pharmacy retail chain with offline GSP-compliant drugstores and a national online drug sales license, integrating pharmaceutical marketing and services and operating both offline stores and online flagship stores on major Chinese e-commerce platforms.[3]

Industry: Non-Academic Healthcare

Partnerships

China SXT Pharmaceuticals (non-binding LOI in 2021 for proposed acquisition of 70% equity interest in Renji Chain)

Beyond the preview

Go deeper on Jiangsu Renji Pharmaceutical Chain.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangsu Renji Pharmaceutical Chain.

Explore the full profile